Replimune Group OverviewReplimune Group EBIT
EBIT (Earnings Before Interest and Taxes) analysis for REPL.
Quarterly EBIT
-$72.31M
↑ 12.48% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$310.90M
↓ 17.11% YoY
Trailing 12 months ending Mar 31, 2026
Replimune Group OverviewEBIT (Earnings Before Interest and Taxes) analysis for REPL.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026